Next Article in Journal
Advances in Optical Detection of Human-Associated Pathogenic Bacteria
Next Article in Special Issue
Health-Promoting Compounds in Stevia: The Effect of Mycorrhizal Symbiosis, Phosphorus Supply and Harvest Time
Previous Article in Journal
Momordica charantia Extract Protects against Diabetes-Related Spermatogenic Dysfunction in Male Rats: Molecular and Biochemical Study
Previous Article in Special Issue
Chemical Profile and Antimicrobial Activity of the Fungus-Growing Termite Strain Macrotermes Bellicosus Used in Traditional Medicine in the Republic of Benin
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 25
Issue 22
10.3390/molecules25225257
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical and Biological Activity Studies on Nasturtium officinale (Watercress) Microshoot Cultures Grown in RITA® Temporary Immersion Systems

by
Marta Klimek-Szczykutowicz
1,
Michał Dziurka
2,
Ivica Blažević
3,
Azra Đulović
3,
Sebastian Granica
4,
Izabela Korona-Glowniak
5,
Halina Ekiert
1 and
Agnieszka Szopa
1,*
1
Chair and Department of Pharmaceutical Botany, Faculty of Pharmacy, Jagiellonian University, Medical College, Medyczna 9, 30-688 Kraków, Poland
2
Polish Academy of Sciences, The Franciszek Górski Institute of Plant Physiology, Niezapominajek 21, 30-239 Kraków, Poland
3
Department of Organic Chemistry, Faculty of Chemistry and Technology, University of Split, Ruđera Boškovića 35, 21000 Split, Croatia
4
Department of Pharmacognosy and Molecular Basis and Phytotherapy, Medical University of Warsaw, Banacha 1, 02-097 Warszawa, Poland
5
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland
*
Author to whom correspondence should be addressed.
Molecules 2020, 25(22), 5257; https://doi.org/10.3390/molecules25225257
Submission received: 29 September 2020 / Revised: 5 November 2020 / Accepted: 9 November 2020 / Published: 11 November 2020
(This article belongs to the Special Issue Biological Activities of Natural Products)
Browse Figures
Versions Notes

Abstract

:
The main compounds in both extracts were gluconasturtiin, 4-methoxyglucobrassicin and rutoside, the amounts of which were, respectively, determined as 182.93, 58.86 and 23.24 mg/100 g dry weight (DW) in biomass extracts and 640.94, 23.47 and 7.20 mg/100 g DW in plant herb extracts. The antioxidant potential of all the studied extracts evaluated using CUPRAC (CUPric Reducing Antioxidant Activity), FRAP (Ferric Reducing Ability of Plasma), and DPPH (1,1-diphenyl-2-picrylhydrazyl) assays was comparable. The anti-inflammatory activity of the extracts was tested based on the inhibition of 15-lipoxygenase, cyclooxygenase-1, cyclooxygenase-2 (COX-2), and phospholipase A2. The results demonstrate significantly higher inhibition of COX-2 for in vitro cultured biomass compared with the herb extracts (75.4 and 41.1%, respectively). Moreover, all the studied extracts showed almost similar antibacterial and antifungal potential. Based on these findings, and due to the fact that the growth of in vitro microshoots is independent of environmental conditions and unaffected by environmental pollution, we propose that biomass that can be rapidly grown in RITA® bioreactors can serve as an alternative source of bioactive compounds with valuable biological properties.

1. Introduction

Plant in vitro cultures are an important part of biotechnological studies, which aid in investigating the potential of obtained biomass to be used as a source of secondary metabolites obtained, for example, from rare and protected plant species. The culture biomass can thus be used in pharmaceutical, cosmetological, and agricultural industries. Furthermore, the large-scale plant in vitro cultures allow for producing those compounds with limited natural resources or resources threatened by overexploitation [1,2].
In order to scale up the biomass production and secondary metabolite production, the special bioreactors for plant propagation are applied in plant biotechnology [3]. Depending on the environment in the cultivation chamber, four types of bioreactors are distinguished in plant biotechnology, namely liquid-phase bioreactor, gas-phase bioreactor, hybrid bioreactor, and temporary immersion system (TIS) [3]. TIS enables the cultivation of plant in vitro cultures in submerged and nonsubmerged cycles. In this system, in vitro cultures are maintained by immersing in liquid medium without mechanical stress and with good gas exchange [1,2,3]. Several plant in vitro cultures have been cultured in the TIS bioreactors for optimizing the production of secondary metabolites. For example, compounds including xanthone, benzophenone, and bioflavonoids were obtained from Cyclopia genistoides [4], flavonoids and other phenolics from Rosa rugosa and Castilleja tenuiflora [5,6], galantamine from Leucojum aestivum [7], and camptothecin from Camptotheca acuminata [8].
Nasturtium officinale R. Br. (Robert Brown), known as watercress, is a perennial, aquatic, or semiaquatic plant species with creeping or floating stems, which colonizes gently flowing and shallow streams in its natural habitat. It belongs to Brassicaceae family and is classified by the International Union for Conservation of Nature (IUCN) in the Red List of Threatened Species, as a plant of least concern in Europe. This species has different statuses in European countries; for instance, in Austria and Sweden, it is considered as an endangered species, while in Poland it is partly endangered [9]. The monograph of the N. officinale herb is present in German Commission E Monographs (Phyto-Therapy) [10]. The European Food Safety Authority (EFSA) has classified N. officinale as a safe vegetable under the group “Leaf vegetables, herbs and edible flowers” [11]. The major compounds found in the N. officinale herb are glucosinolates (GSLs), isothiocyanates, polyphenols (flavonoids, phenolic acids, proanthocyanidins), terpenoids (including carotenoids), vitamins (B1, B2, B3, B6, E, C), and bioelements [12,13,14,15]. An analysis of different plant organs from N. officinale such as leaves, stem, flower, and root indicated the presence of phenylalanine derivatives (gluconasturtiin and glucotropaeolin), methionine derivatives (glucoiberin, 7-(methylsulfinyl)heptyl GSL, glucohirsutin), and tryptophan derivatives (glucobrassicin, 4-hydroxyglucobrassicin, 4-methoxyglucobrassicin). Among these, the important compound in N. officinale is gluconasturtiin, the content of which is over 10-fold higher than the other GSLs [15,16]. The presence of these compounds and their breakdown products—isothiocyanates—is mostly responsible for the observed antioxidant, anticancer, antibacterial, and anti-inflammatory effects of the N. officinale extracts [17,18,19,20].
Previous biotechnological studies on N. officinale in vitro cultures focused on micropropagation and analyzing the ability of the plant to regenerate from callus culture [21] as well as on its genetic transformation by Agrobacterium rhizogenes and the resulting impact on the production of GSLs [22,23]. In our latest studies, we optimized the condition under which microshoots can be grown in agar and agitated cultures. We chose Murashige and Skoog (MS) medium with 1 mg/L 6-benzyladenine (BA) and 1 mg/L 1-naphthaleneacetic acid (NAA) as the appropriate medium for the cultivation of N. officinale, and determined the optimal growth period as 20 days for agar cultures and 10 days for agitated cultures [24]. In addition, we investigated and confirmed the ability to bioaccumulate several bioelements, such as calcium, chromium, copper, iron, lithium, magnesium, selenium, and zinc, in the biomass of N. officinale from agitated cultures [25].
These analyses prompted us to conduct further works on N. officinale and study the production of secondary metabolites in in vitro cultures of this species and evaluate its biological activity in highly productive TIS bioreactors.
The aim of the present research was to establish N. officinale RITA® TIS microshoot cultures and to estimate the GSLs and phenolic compounds profiles. The extracts obtained from biomass were also evaluated for their antioxidant, anti-inflammatory, antibacterial, and antifungal activities. The results were compared with those of the herb extract obtained from the aerial parts of the parent plant with flowers.

2. Results

2.1. Microshoots Appearance and Biomass Growth

The appearance of tested bioreactor cultures was dependent on the duration of growth period (Figure 1a,b). After 10 and 20 days, the number of shoots was large. The microshoots had dark green-colored leaves. A great increase in the fresh biomass was observed during the 10- and 20-day growth periods, while after 30 days, the biomass died and was not analyzed.
High growth index (Gi) values were obtained for the dry biomass. Depending on the culture duration, the increases in dry biomass, expressed by Gi, ranged from 16.54 (after 10 days) up to 31.71 (after 20 days). The Gi estimated for the cultures grown over 20 days was 1.9-fold higher than the increase recorded after 10 days.

2.2. Individual and Total GSLs Contents

The results obtained from the analysis of individual and total GSLs contents are presented in Table 1 and Table 2. For in vitro cultures, the total GSLs content was found to be dependent on the duration of growth periods, i.e., 113.70 and 261.97 mg/100 g dried weight (DW) after 20 and 10 days, respectively (Table 1). In the case of N. officinale herb extract, the total GSLs content was 799.47 mg/100 g DW (Table 1).
After 10 and 20 days of growth, three main GSLs were found in the extracts of N. officinale bioreactor cultures using UHPLC-DAD-MS/MS: phenylalanine-derived GSLs (gluconasturtiin), followed by tryptophan-derived GSLs (glucobrassicin and 4-methoxyglucobrassicin) (Table 2, Figure 2). The highest content of gluconasturtiin (182.93 mg/100 g DW) was obtained in the bioreactor cultures after 10 days of growth, while its content decreased after 20 days (56.32 mg/100 g DW). The content of 4-methoxyglucobrassicin determined after 10 and 20 days was similar—58.86 and 49.76 mg/100 g DW, respectively. Glucobrassicin was accumulated in lower amounts in the tested extracts: 20.18 mg/100 g DW after 10 days and 7.62 mg/100 g DW after 20 days (Table 2). Additionally, methionine-derived GSLs (glucohirsutin and 7-(methylsulfinyl)heptyl GSL) were detected in the trace amounts in the biomass extracts.
The analysis of the extracts from the N. officinale herb revealed the presence of four main GSLs: phenylalanine-derived GSL (gluconasturtiin, 640.94 mg/100 g DW), methionine-derived GSLs (7-(methylsulfinyl)heptyl GSL, 92.27 mg/100 g DW and glucohirsutin, 42.79 mg/100 g DW), and tryptophan-derived GSLs (4-methoxyglucobrassicin, 23.47 mg/100 g DW). In addition, other GSLs were found in trace amounts, which included a methionine-derived compounds (glucohesperin, 7-(methylsulfanyl)heptyl GSL and 8-(methylsulfanyl)octyl GSL), and a tryptophan-derived compound (glucobrassicin) (Table 2, Figures S1 and S2).

2.3. Spectrophotometric Analysis of Total Polyphenol and Flavonoid Contents

The Folin–Ciocalteu (F-C) assay revealed the highest total polyphenol contents (3.74 mmol TE (trolox equivalent)/100 g DW) for the microshoots cultured over 10 days in bioreactor system, while the lower polyphenol contents (3.10 mmol TE/100 g DW) were detected for the biomass maintained for 20 days (Table 1). In the herb extracts, the total polyphenol content equaled 2.70 mmol TE/100 g DW (Table 1).
The total flavonoid content in the case of in vitro culture extracts was calculated as 0.95 and 1.64 mmol RE (rutoside equivalent)/100 g DW after 20 and 10 days of growth, respectively (Table 1). In the herb extract, the total flavonoid content was estimated at 1.89 mmol RE/100 g DW (Table 1).

2.4. Chromatographic Analysis of Polyphenol Contents

The qualitative analysis of polyphenol compounds by the UHPLC-DAD-ESI-MS method showed the presence of p-coumaric (24) and ferulic acid (25) among phenolic acids in the in vitro biomass extracts. In addition, the derivatives of protocatechuic (14), caffeic (15, 18, 22), phenolic (derivatives) (17,21) and sinapic acids (29) were detected. Among the flavonoids, rutoside (26) was detected in these extracts. The presence of three undefined compounds (16, 31, 32) was also noted (Table 3, Figure 3).
In the extracts of the parent plant herb, the presence of four phenolic acids was confirmed: gallic (9), protocatechuic (10), p-coumaric (24) and ferulic (25) acids. In addition, the derivatives of protocatechuic (14), phenolic (21), caffeic (22, 23) and sinapic (29) acids were detected. Among flavonoids, rutoside (26), isoquercitrin (27) and kaempferol O-rhamnohexoside (28) were detected in the extracts of the N. officinale herb. Furthermore, six undefined compounds (11, 12, 13, 30, 31, 32) were detected in these extracts (Table 3).
The amounts of four phenolic acids (p-coumaric, gallic, ferulic and protocatechuic acids) and three flavonoids (rutoside, isoquercitrin and kaempferol O-rhamnohexoside) detected using the UHPLC-DAD-ESI-MS analysis were estimated quantitatively by the HPLC-DAD method (Table 3). Quantitative analysis showed that the dominant compound in the extracts from in vitro cultures was ferulic acid; its content was dependent on the growth cycles and was estimated at 9.28 and 1.66 mg/100 g DW after 10 and 20 days of growth period, respectively. The content of p-coumaric acid was similar at 10 (1.26 mg/100 g DW) and 20 days (1.05 mg/100 g DW) of growth cycle (Table 3).
The amount of rutoside was calculated as 3.06 and 23.24 mg/100 g DW after 10 and 20 days of growth period, respectively (Table 3).
Quantitative analysis of the N. officinale herb extracts using the HPLC-DAD method showed high contents of protocatechuic acid (196.11 mg/100 g DW) and isoquercitrin (57.05 mg/100 g DW). The other phenolic acids were found to range from 3.10 (p-coumaric acid) to 26.55 mg/100 g DW (gallic acid). In the case of flavonoids, the content of rutoside was determined as 7.20 mg/100 g DW and kaempferol O-rhamnhexoside as 0.18 mg/100 g DW. The total content of flavonoids in the analyzed herb extract was 64.43 mg/100 g DW (Table 3).

2.5. Antioxidant Potential

In the antioxidant potential analysis, conducted using CUPRAC (CUPric reducing antioxidant activity), FRAP (Ferric Reducing Ability of Plasma), and DPPH (1,1-diphenyl-2-picrylhydrazyl) assays, a higher antioxidant potential was shown by the CUPRAC method for the biomass harvested after 10 days (3.19 mmol TE/100 g DW) compared with the cultures grown over 20 days (2.46 mmol TE/100 g DW) (Table 4). The antioxidant potential evaluated for the extracts from the N. officinale herb equaled 4.45 mmol TE/100 g DW (Table 4).
Similarly, in the FRAP analysis, a higher antioxidant potential was detected for microshoot extracts grown for 10 days (0.75 mmol TE/100 g DW) than for 20 days (0.67 mmol TE/100 g DW) (Table 4). In the case of extracts from N. officinale herb, the antioxidant potential was equal to 0.76 mmol TE/100 g DW (Table 4).
In the DPPH analysis, stronger antioxidant potential was observed for the extracts from bioreactor cultures grown over 20 days (23.79 mmol TE/100 g DW) than the microshoots grown over 10 days (21.63 mmol TE/100 g DW) (Table 4). For the herb extract, the antioxidant potential was estimated to be 26.32 mmol TE/100 g DW (Table 4).

2.6. Anti-Inflammatory Activity

The anti-inflammatory activity was confirmed based on the in vitro inhibition of 15-lipoxygenase (15-LOX), cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and phospholipase A2 (sPLA2) enzymes. The extracts of N. officinale biomass maintained in vitro over 10 days in RITA® bioreactors showed moderate inhibition of 15-LOX and very low inhibition of sPLA2. However, a relatively high inhibitory activity was observed against COX-1 and COX-2 enzymes (Table 5).
The N. officinale bioreactor cultures inhibited 15-LOX at a level of 15.9% at 16.5 µg/mL. The most promising results were detected for in vitro inhibition against COX-1 and COX-2 enzymes. Between these two, the highest inhibition was noted against COX-2—75.4, 73.5, and 34.5% at 1.7, 16.5, and 165.0 µg/mL, respectively (Table 5). Evaluation of COX-1 inhibition showed that N. officinale bioreactor cultures inhibited this enzyme at a significant level of 40.5, 33.3, and 29.2% at a concentration of 16.5, 165.0, and 1.7 µg/mL, respectively (Table 5). In the case of sPLA2, the 3.8, 1.3, and 0.7% inhibition was observed for the in vitro extracts at 165.0, 16.5, and 1.7 µg/mL, respectively (Table 5).
Evaluation of 15-LOX inhibition by N. officinale herb extracts revealed that this enzyme was inhibited at 19.5% by the extract at a concentration of 16.5 µg/mL. The highest inhibition was noted for the COX-1 enzyme—42.6, 41.1, and 36.3% at 1.7, 165.0, and 16.5 µg/mL, respectively (Table 5). Evaluation of COX-2 inhibition showed that the herb extracts inhibited this enzyme at significant levels of 41.1, 39.8, and 33.0% at concentrations of 16.5, 165.0, and 1.7 µg/mL, respectively (Table 5). For the sPLA2 enzyme, the 5.3 and 2.1% inhibitions were observed at 1.7 and 165.0 µg/mL, respectively (Table 5).

2.7. Antimicrobial Activity

The N. officinale 10-days bioreactor microshoot cultures and herb extracts were tested for their antimicrobial properties with reference strains of bacteria and fungi presented in Table 6.
The minimal inhibitory concentration (MIC) determined for the extracts of in vitro N. officinale cultures ranged from 1.25 to 10 mg/mL (Table 6). For the tested Gram-positive bacterial strains (S. aureus and S. epidermidis), the MIC was equal to 5 mg/mL, while for Gram-negative bacteria, the values differed ranging from 1.25 (H. pylori) to 10 mg/L (E. coli and P. aeruginosa). The minimum bactericidal concentration (MBC) of the in vitro culture extracts was estimated at 1.25–20 mg/mL. Among the tested bacterial strains, the highest MBC (20 mg/mL) was noted for S. aureus, while the lowest (1.25 mg/L) was detected for H. pylori. The highest MBC/MIC ratio of 4 was obtained for S. aureus, whereas for other tested strains the ratio was lower than 4 (Table 6).
In the case of N. officinale herb extracts, the MIC for the tested bacterial strains ranged from 1.25 to 10 mg/mL (Table 6). For the Gram-positive bacterial strains, the MIC values were equal to 5 (S. aureus) and 10 mg/mL (S. epidermidis). For Gram-negative bacterial strains, the MIC values differed and ranged from 1.25 (H. pylori) to 10 mg/mL (E. coli and P. aeruginosa). The MBC values were calculated at 1.25–20 mg/mL. The highest MBC (20 mg/mL) was estimated for S. aureus, and the lowest (1.25 mg/mL) for H. pylori. As observed with biomass extracts, the highest MBC/MIC ratio of 4 was obtained for S. aureus, while for other strains the ratio was lower than 4 (Table 6).
For bioreactor microshoot culture extracts, the MIC for the tested fungal strains ranged from 1.25 to 20 mg/mL. The highest MIC (20 mg/mL) was determined for C. parapsilosis, and the lowest (1.25 mg/mL) for T. menthagrophytes. The highest minimum fungicidal concentration (MFC) (over 20 mg/mL) was noted for A. niger and P. chrysogenum, and the lowest (2.5 mg/mL) for T. menthagrophytes. The MFC/MIC ratio ranged from 1 to 4 for all tested strains (Table 6).
For N. officinale herb extracts, the MIC for fungal strains ranged from 2.5 to 10 mg/mL. The highest MIC (10 mg/mL) was calculated for C. glabrata, C. parapsilosis, A. niger, P. chrysogenum, and M. canis, while the lowest (2.5 mg/mL) was detected for T. menthagrophytes. The highest MFC (over 20 mg/mL) was estimated for A. niger and P. chrysogenum, whereas the lowest (2.5 mg/mL) was estimated for T. menthagrophytes. The MFC/MIC ratio ranged from 1 to 2 for all tested strains (Table 6).

3. Discussion

This study is the first to establish the RITA® bioreactor microshoot cultures of N. officinale involved the phytochemical studies and analysis of biological activities. We focused on the production of GSLs and two groups of polyphenols—phenolic acids and flavonoids. Biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties, were tested for the first time in extracts obtained from N. officinale bioreactor microshoot cultures. The results obtained for these extracts were compared to those of the raw material.
A high amount of biomass was obtained from bioreactor microshoot cultures. The highest Gi factor of dried biomass (31.71) was recorded after 20 days of growth period. A comparison of these results with those of our former studies, which included N. officinale agar and agitated microshoot cultures [24], showed higher biomass increments in the studied RITA® bioreactor cultures. In agitated microshoot cultures, the highest Gi (10.48) was 3.0-fold lower than in the bioreactor cultures. Comparing the highest Gi of bioreactor and agar cultures (5.05), a 6.3-fold increase was noted in bioreactor cultures than in agar cultures [24]. Jesionek et al. [26] studied biomass increases in Ledum palustre microshoot cultures in RITA® bioreactors. After 28 days of in vitro culturing of L. palustre, the Gi of fresh weight was equal to 2.8, and in 20 days the Gi of N. officinale bioreactor cultures was 11.3-fold higher than that of L. palustre in vitro cultures [26]. For Schisandra chinensis in vitro microshoot cultures maintained in RITA® bioreactors, the Gi factor was equal to 3.49 and 10.48 after 30 and 60 days, respectively [27]. The maximal Gi factor calculated for N. officinale bioreactor microshoot cultures was 9.1- and 3.0-fold higher than that of S. chinensis bioreactor cultures, respectively [27].
Analysis of the total GSLs contents indicated the differences between the N. officinale herb and bioreactor microshoot cultures (Table 1). In bioreactor microshoot cultures, the highest GSLs total content was detected after 10 days of growth period (261.97 mg/100 g DW), which was 3.0-fold lower than that of the N. officinale herb (799.47 mg/100 g DW). The studied material from the parent plant was whole herb (stems with leaves and flowers), while in vitro cultures are recognized as less morphologically differentiated (microshoot cultures). Former studies performed by Jeon et al. [15] showed that flowers of N. officinale contain higher content of GSLs in comparison to other herb organs. Moreover, in vitro cultures are known as systems that produce often lower levels of compounds compared to ground plants [28,29]. Nevertheless, in vitro culture systems distinguished by many qualities that support for their attractiveness as an object of promising scientific research [30].
In our previous studies [24], the highest total content of GSLs in the N. officinale agar and agitated cultures growing on MS medium containing 1 mg/L BA and 1 mg/L NAA was 164.97 and 182.80 mg/100 g DW, respectively. In N. officinale bioreactor microshoot cultures, the total GSLs content was 1.6-fold higher than in the agar cultures. The growth periods maintained were different—10 days for bioreactor cultures and 20 days for agar cultures, and, in turn, the Gi indexes also differed—16.54 and 3.79, respectively. Comparing the N. officinale agitated and bioreactor microshoot cultures, it was found that the total GSLs content was 1.4-fold higher in the bioreactor cultures than in the agitated cultures (Table 1) [24]. However, in both cultures, the maximal total content was observed after 10 days of growth period, while the Gi indexes was much higher for bioreactor cultures (16.54) than for agitated cultures (5.29) [24].
In another study, the total GSLs content in the N. officinale herb harvested at an interval of 1 month was estimated by spectrophotometry. The total content determined in our study was in compliance with the range of total GSLs found in this study at 592.21–1752.80 mg/100 g DW [31].
Our study shows that the GSLs contents differed in the extracts from bioreactor cultures and from the N. officinale herb. For methionine-derived GSLs (7-(methylsulfinyl)heptyl GSL and glucohirsutin), the content in herb extracts was significantly higher than in the extracts from bioreactor cultures. The main compound detected in both extracts was phenylalanine-derived GSL (gluconasturtiin); in the extracts from the herb, the content of gluconasturtiin was 3.5-fold higher than in the extracts from bioreactor cultures. In plant in vitro cultures, a 2.5-fold higher content of tryptophan-derived GSL (4-methoxyglucobrassicin) was found compared to the extracts from the herb. The content of another tryptophan-derived compound (glucobrassicin) was also significantly higher in the extracts from in vitro cultures than in the herb extracts (Table 2, Figure 2).
The qualitative and quantitative analysis of extracts from different organs of N. officinale (leaf, stem, root, flower, and seed) was performed by Jeon et al. using the HPLC-UV technique [15]. This team reported the presence of eight GSLs in the studied extracts: glucoiberin, glucotropaeolin, 4-hydroxyglucobrassicin, 7-(methylsulfinyl)heptyl GSL, glucohirsutin, glucobrassicin, 4-methoxyglucobrassicin, and gluconasturtiin. The authors found that gluconasturtiin was the main GSL present in the highest amount in flowers (7.39 mg/100 g DW). This content was 86.7-fold lower compared to our herb extracts and 24.8-fold lower than in the extracts obtained from in vitro cultures.
Extracts from N. officinale shoots were also studied by Giallourou et al. [16]. The identification and quantification of GSLs were performed using the LC-MS/MS technique. In the analyzed methanolic extracts, five GSLs were identified: gluconasturtiin, glucobrassicin, 4-hydroxyglucobrassicin, 4-methoxyglucobrassicin, and 7-(methylsulfinyl)heptyl GSL. The main compound detected in their study was gluconasturtiin at a content of 176.00 mg/100 g DW, which was 3.6-fold lower than that of our extracts from herb and was comparable to 10-day extracts of bioreactor microshoot cultures.
The N. officinale agar in vitro cultures were investigated by Rubin et al. [32]. This team reported two GSLs—gluconasturtiin and glucotropaeolin—in the methanolic extracts from the in vitro agar shoot cultures grown for 30 days on MS agar medium without plant growth regulators, containing 30 g/L sucrose and 4 g/L agar. The amount of gluconasturtiin (140.40 mg/100 g FW) determined in their study was 1.3-fold lower than in our bioreactor microshoot cultures harvested after 10 days of growth [32].
In our study, the higher total polyphenol content (3.74 mmol TE/100 g DW) was determined by the F-C assay for the microshoots cultured over 10 days, which was 1.4-fold higher in comparison to the herb extracts (Table 1). For the first time, studies on the total flavonoid pool in N. officinale in vitro cultures were performed in this study. The spectrophotometric analysis of the total flavonoid pool confirmed the greater contents of these compounds in the extracts from RITA® bioreactor cultures grown over 10 days compared to those grown over 20 days, and these results were similar to the results obtained for herb extracts (Table 1).
The differences in the qualitative content of phenolic acids and flavonoids between the extracts from N. officinale bioreactor microshoot cultures and the N. officinale herb were confirmed using the UHPLC-DAD-ESI-MS method (Table 3). In the extracts of RITA® bioreactor microshoot cultures, two phenolic acids (p-coumaric and ferulic acids) and one flavonoid (rutoside) were detected (Table 3). On the other hand, in the extracts of the herb, the presence of four phenolic acids (p-coumaric, gallic, ferulic and protocatechuic acids) and three flavonoids (isoquercitrin, kaempferol O-rhamnohexoside, and rutoside) was confirmed. Among flavonoids, only the presence of rutoside was confirmed in the extracts from bioreactor microshoot cultures. The maximal content of rutoside in these extracts (23.24 mg/100 g DW) was 3.2-fold higher than in the extracts from the herb (7.20 mg/100 g DW) (Table 3). For phenolic acids, they were not studied before in N. officinale in vitro cultures.
In the study performed by Zeb, a qualitative analysis of phenolic compounds in N. officinale leaf extracts was carried out [33], and the presence of caffeoylmalic acid, caftaric acid, coumaric acid derivative, p-coumaric acid, p-coumaric acid derivative, ferulic acid derivative, two gallic acid derivative, p-hydroxybenzoic acid, and sinapic acid was reported. In our extracts from the N. officinale herb, the presence of caffeoylmalic acid, caftaric acid, and p-hydroxybenzoic acid was not confirmed. Moreover, we detected protocatechuic acid as the main phenolic compound in herb extracts (Table 3). This author confirmed the presence of three flavonoids—apigenin, quercetin-3-(caffeoyldiglucoside)-7-glucoside, and kaempferol-3-(caffeoyldiglucoside)-7-rhamnoside—in the leaf extracts. However, in our study, we detected three different flavonoids—isoquercitrin, kaempferol O-rhamnohexoside, and rutoside—in the herb extracts (Table 3).
The young-baby leaves of N. officinale were analyzed in the study of Aires et al. [34]. Their evaluation of qualitative and quantitative contents of phenolic acids in the methanol:water (v/v) extracts confirmed the presence of four phenolic acids: caffeic, chlorogenic, dicaffeoyltartaric, and gallic acids. Similarly, in our study, we confirmed the presence of gallic acid and three another phenolic acids—p-coumaric, ferulic and protocatechuic acids—in herb extracts. The content of gallic acid (1.60 mg/100 g DW) determined in the study of Aires et al. was 16.6-fold lower in comparison to our results (Table 3). The authors also confirmed the presence of two flavonoids in their leaf extracts: isorhamnetin and rutoside. In our herb extracts, we detected the presence of rutoside, isoquercitrin, and kaempferol O-rhamnohexoside, among flavonoids (Table 3). The total content of analyzed polyphenols in our herb extracts was 1.5-fold lower than in the extracts from young-baby leaves [34].
The antioxidant potential of the studied RITA® TIS-grown microshoot and herb extracts was analyzed using three assays: CUPRAC, FRAP, and DPPH.
In the CUPRAC assay, the antioxidant potential of herb extracts (4.45 mmol TE/100 g DW) was found to be 1.4-fold higher than in the extracts from RITA® bioreactor cultures (3.19 mmol TE/100 g DW) (Table 4). In our former studies [24], we investigated the antioxidant potential using the CUPRAC assay for agar and agitated cultures growing on MS medium containing 1 mg/L BA and 1 mg/L NAA. For agar cultures, the highest antioxidant potential was confirmed after 20 days (3.26 mmol TE/100 g DW) and for agitated cultures after 10 days (2.65 mmol TE/100 g DW). The maximal antioxidant potential estimated for bioreactor cultures was similar to that of agar cultures and 1.2-fold higher than that of agitated cultures (Table 4) [24].
In the FRAP method, the maximal antioxidant potential (0.75 mmol TE/100 g DW) of bioreactor-grown cultures was found to be almost identical to that of the plant material (0.76 mmol TE/100 g DW) (Table 4). In previous studies [24], for the variant medium containing 1 mg/L BA and 1 mg/L NAA, the determination of antioxidant potential using the FRAP method showed higher potential for agar cultures (0.90 mmol TE/100 g DW) and lower for agitated cultures (0.55 mmol TE/100 g DW) after 10 days, which was, respectively, 1.2-fold higher and 1.4-fold lower in comparison with the bioreactor cultures studied in the present work (Table 4) [24].
The DPPH assay showed that the antioxidant potential reached the maximal value in RITA® bioreactor cultures (23.79 mmol TE/100 g DW) and was 1.1-fold lower than in the herb extract (26.32 mmol TE/100 g DW) (Table 4). The antioxidant potential of N. officinale was also evaluated for agar and agitated cultures using the DPPH method in our previous studies [24]. For the variant medium containing 1 mg/L BA and 1 mg/L NAA, the DPPH method showed the highest antioxidant potential for agar cultures after 10 days (3.02 mmol TE/100 g DW) and agitated cultures after 20 days (19.57 mmol TE/100 g DW), which was 7.9- and 1.2-fold lower in comparison to the bioreactor cultures, respectively (Table 4) [24].
The anti-inflammatory assays confirmed the differences between bioreactor microshoots and herb extracts (Table 5). For 15-LOX, a 1.2-fold higher inhibition was observed for a similar concentration of plant extract compared to the RITA® bioreactor microshoot extracts. In both extracts, the results were lower for NDGA used as a control (Table 5). For the COX-1 enzyme, the highest inhibition was shown by plant extracts at a concentration of 1.7 µg/mL, which was similar to the inhibition by bioreactor microshoot extracts achieved at a concentration of 16.5 µg/mL. In comparison to the control used for this enzyme (ibuprofen), the inhibition by both extracts was about 1.9-fold higher (Table 5). The highest differences were noted for the COX-2 enzyme; the strongest inhibition was observed with the bioreactor microshoot extracts, which was 1.8- and 3.6-fold higher than plant extracts and the control (ibuprofen), respectively (Table 5). For sPLA2, the inhibition by both extracts was lower. The highest inhibition was obtained for herb extracts, and it was almost 1.5-fold higher than bioreactor extracts and 17-fold lower in comparison to the control (thioetheramide-PC) (Table 5).
For the first time, we performed inhibition analysis for extracts from N. officinale herb and bioreactor microshoot cultures against 15-LOX, COX-1, COX-2, and sPLA2 enzymes. In the majority, the dose-dependent tendency of selected enzymes inhibition by plant extracts was observed. Nevertheless, inverse dose dependence can be noticed. It should be contributed to a wide confidence interval between dilutions, and thus the lack of significant difference. This can be seen for COX-1 inhibition by in vitro extract at 165 and 16.5 µg/mL, and by ex vitro plant material extract at a whole range of concentrations. However, the pronounced exceptions occurred for sPLA2 inhibition in the case of plant material and COX-2 in the case of in vitro culture extracts. Still, the inhibition activity of both extracts against sPLA2 is rather weak and thus of low significance, but this deviation from the competitive inhibition mechanism can also suggest the occurrence of inhibitor acceleration of the enzyme by active substances from ex vitro plant extract. The mechanism of inhibitor acceleration relies on allostery and multiple active sites [35]. Still, intriguing is the activity of diluted in vitro extract against COX-2. This result suggests the occurrence of selective COX-2 inhibitor accumulated in in vitro conditions. Our data let us suspect substances related to GSLs metabolism, which activity could be hypothetically suppressed by other co-accumulating secondary metabolites. Afterwards, the dilution activity of higher accumulating GSL-related intermediates is more pronounced. It is known that GSLs can be responsible for the inhibition of LOX- and COX-dependent inflammatory pathways. As reported by Herz et al. [35], isothiocyanates, the precursors of which are GSLs, block the COX and LOX pathway. Burčul et al. [36] showed that GSLs derived isothiocyanates are promising inhibitors of COX-2 enzymes. Almuhayawi et al. [37] showed results that increased accumulation of GSLs is linked with increased inhibition of LOX, COX-1, and COX-2 enzymes. This hypothesis should be confirmed in further studies. On the other hand, plant secondary metabolism is so rich and complicated that it could be concluded that particular properties are resultants of a few probably opposite activities. Thus, a parallel occurrence of components inhibiting as well as increasing the activity is possible due to the natural complexity of such a plant extract. Another study on the anti-inflammatory activity of N. officinale herb extracts focused on reduction in skin inflammation induced by croton oil via glucocorticoid receptor-dependent and NF-κB pathways in mice. The extract from N. officinale inhibited the croton oil-induced ear edema, reduced the infiltration of inflammatory cells and the levels of pro-inflammatory cytokines (MIP-2, IL-1β), and also inhibited the reduction of IkB-α protein expression induced by croton oil [38]. The study by Sadeghi et al. [18] also confirmed that oral intake of hydroalcoholic N. officinale herb extracts inhibited carrageenan-induced paw edema and formalin-evoked paw edema. Additionally, topical application of N. officinale reduced TPA (O-tetradecanoylphorbol-13-acetate)-induced ear edema, decreased swelling, and improved tissue damage [18].
To our best knowledge, this is the first study to analyze the antimicrobial activity of N. officinale biomass extracts from in vitro cultures. The antibacterial activity of N. officinale herb and bioreactor microshoot cultures against Gram-positive and Gram-negative bacteria was confirmed. Estimation of the MBC value allowed for establishing whether the extracts killed the bacteria or inhibited their growth. An antimicrobial agent is usually regarded as bactericidal if its MBC value is no more than four times the MIC value [39]. The MBC/MIC ratio determined for the extracts from bioreactor cultures was 2 and for the herb extracts was 1 (Table 6). Differences in the antifungal activity of extracts were observed for fungal strains, especially C. albicans, C. parapsilosis, T. mentagrophytes, and M. canis. The antimicrobial activity of extracts may result from the production of secondary metabolites which was also confirmed in the study. Moreover, the former studies [40] showed the antibacterial activity of extracts from N. officinale herb toward E. coli, K. pneumoniae, E. faecalis, and B. cereus. In the study of Quezada-Lazaro et al. [41], the antimicrobial activity of the herb extracts against Mycobacterium tuberculosis was confirmed. In the present study, we extended the analyses on these extracts using more fungal and bacterial strains for the first time.

4. Materials and Methods

4.1. Experimental In Vitro Cultures

Initial microshoot cultures of N. officinale were established and maintained as reported previously [25]. Experimental microshoots were cultivated in RITA® TIS bioreactors (VITROPIC, Saint-Mathieu-de-Tréviers, France) (Figure 1 a,b) containing 200 mL of MS medium [42] with 3% (w/v) sucrose and supplemented with 1 mg/L BA and 1 mg/L NAA. The medium was identified as optimal for the cultivation of microshoots in our previous research [24]. The inoculum used in the present study was composed of 4 g microshoots. The nutrient media and biomass samples were collected after a growth period of 10 and 20 days (three series). After 30 days of growth period, the biomass died and was not tested further. The microshoots were grown under continuous exposure to an LED white light (2.75 W/m2) at a temperature of 25 ± 2 °C. The immersion cycle was set to 5 min every 1.5 h, at an aeration rate of 1.0 vvm.

4.2. Parent Plant Material

The Nasturtium officinale R. Br. plant material obtained from the Garden of Medicinal Plants, Faculty of Pharmacy, Jagiellonian University, Medical College, Cracow, Poland, loc. 50.01° N, 19.99° E, in May 2018 (Figure 1c). Voucher specimen (No. 102) has been deposited in the herbarium of this Garden. The material for analyses was lyophilized (Labconco Corporation, Kansas City, MO, USA) before.

4.3. In Vitro Biomass Increments

Biomass increments were measured by weighing biomass obtained after 10 and 20 days of growth period after lyophilization. For dry biomass, the growth index (Gi) was calculated according to the formula: Gi = ( D w 1 − D w 0 ) D w 0   , where Dw1 is the dry weight of microshoots observed at the end of the experiment and Dw0 is the dry weight of the inoculum [4].

4.4. Analysis of GSL Contents Using UHPLC-DAD-MS/MS

4.4.1. Materials and Reagents

Sinigrin was obtained from Sigma-Aldrich (St. Louis, MO, USA). Glucohesperin, glucohirsutin, gluconasturtiin, glucobrassicin, and 4-methoxyglucobrassicin were purchased from Phytoplan Diehm & Neuberger GmbH (Heidelberg, Germany). All other chemicals and reagents used in this study were of analytical grade.

4.4.2. Isolation of dGSLs

Desulfoglucosinolates (dGSLs) were isolated from 100 mg of dried plant material as reported previously [43,44]. First, the plant material was extracted with methanol/H2O mixture (70:30, v/v; Gram-Mol d.o.o, Zagreb, Croatia). The resulting supernatant was loaded on a mini-column filled with DEAE-Sephadex A-25 anion-exchange resin (Sigma-Aldrich, St. Louis, MO, USA). The remaining nonpolar compounds were removed by washing the columns. To create appropriate conditions for the sulfatase reaction, the mini columns were washed once again with 20 mM NaOAc buffer (Merck, Darmstadt, Germany), followed by the addition of sulfatase (type H-1 from Helix pomatia; Sigma-Aldrich, St. Louis, MO, USA). The column was left overnight to allow the reaction to occur, and dGSLs were eluted the next day with ultrapure H2O (Merck Millipore, Burlington, MA, USA).

4.4.3. UHPLC-DAD-MS/MS Analysis of dGSLs

This analysis was performed on a UHPLC-DAD-MS/MS apparatus (Ultimate 3000RS with TSQ Quantis MS/MS detector; Thermo Fischer Scientific, Waltham, MA, USA) using a Hypersil GOLD column (3.0 µm, 3.0 × 100 mm; Thermo Fischer Scientific, Waltham, MA, USA). A gradient consisting of solvent A (50 μM NaCl in H2O) and solvent B (acetonitrile:H2O, 30:70, v/v) was applied at a flow rate of 0.5 mL/min as follows: 0.14 min, 96% A and 4% B; 7.84 min, 14% A and 86% B; 8.96 min, 14% A and 86% B; 9.52 min, 5% A and 95% B; 13.16 min, 5% A and 95% B; 13.44 min, 96% A and 4% B; and 15.68 min, 96% A and 4% B. The column temperature was held at 25 °C, and the injection volume was 5 µL. The system was operated in the positive ion electrospray mode, with the electrospray interface H-ESI operating at a capillary voltage of 3.5 kV and a temperature of 350 °C. The signals were recorded at 227 nm by a DAD. dGSLs were quantified using an external calibration curve of pure desulfosinigrin (range from 13.56 to 542.50 µM). For each individual dGSL, response factors (RPFs) were taken into account in accordance with the literature as follows: RPF 1.0 for 1, 1.1 for 3 [45], 0.95 for 4, 0.29 for 5, and 0.25 for 6 [46]; arbitrary 1.0 for 2.

4.5. Total Phenolic Assay

Lyophilized (Labconco Corporation, Kansas City, MO, USA) and pulverized biomass obtained from in vitro cultures and from parent plant material was weighted (0.2 g) and extracted twice in 4 mL of methanol (STANLAB, Lublin, Poland) under sonication for 20 min (ultrasonic bath; POLSONIC 2, Warsaw, Poland). The extracts were centrifuged (7 min, 2000× g; MPW-223E; MPW, Warsaw, Poland) and filtered (0.22 μm syringe filters; Millex® GP; Merck Millipore, Burlington, MA, USA). Total phenolic content was measured as described by Singelton et al. [47] with modifications reported by Bach et al. [48]. Water-diluted F-C reagent (5/2, v/v, 0.45 mL) was mixed with the studied extracts (100 μL). After 10 min, saturated Na2CO3 (0.45 mL) was added, and the samples were incubated for 2 h in dark at 25 °C. The samples were centrifuged and transferred to 96-well plates, and their absorbance was measured at 760 nm (Synergy II reader; Biotek, Winooski, VT, USA). The amounts of phenolic compounds were determined and expressed as TE in mmol/100 g DW. The analysis was done in triplicate (including reagents blank).

4.6. Total Flavonoid Assay

Total flavonoid content was estimated spectrophotometrically according to a method proposed by Ramos et al. [49]. Briefly, 100 μL of methanolic extract (prepared as described in Section 4.5) was mixed with 40 μL of 10% AlCl3 and 860 μL of 5% acetic acid in methanol. The samples were incubated for 20 min at room temperature and transferred to 96-well plates, and their absorbance was recorded at 425 nm (Synergy II, Biotek, Winooski, VT, USA). The amounts of flavonoids were determined and expressed as RE in mmol/100 g DW.

4.7. Qualitative Analysis of Phenolics by UHPLC-DAD-ESI-MS

This analysis was performed using an Ultimate 3000 series system (Dionex, Idstein, Germany), which was equipped with a dual low-pressure gradient pump with a vacuum degasser, an autosampler, a column compartment, and a DAD coupled with an Amazon SL ion-trap mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany). Methanolic extract (prepared as described in Section 4.5) was used for the analysis. Compounds were separated from the analyzed extract with a Kinetex XB-C18 analytical column (100 × 2.1 mm × 1.7 µm; Phenomenex, Torrance, CA, USA). Temperature of the column was maintained at 25 °C. Elution was done with a mobile phase A (0.1% HCOOH in deionized water) and a mobile phase B (0.1% HCOOH in acetonitrile) in a multistep gradient as follows: 0 min, 1% B; 60 min, 26% B; and 90 min, 95% B. The flow rate was set to 0.300 mL/min during the analysis of the extracts and standards. Five microliters of each sample was introduced to the column using the autosampler. UV–Vis spectra were recorded at the wavelength range of 200–450 nm, and chromatograms were acquired at 254 and 325 nm. The eluate was introduced without splitting into the Amazon SL ion-trap mass spectrometer equipped with an ESI interface. The parameters for the ESI source were set as follows: nebulizer pressure, 40 psi; dry gas flow, 9 L/min; dry temperature, 300 °C; and capillary voltage, 4.5 kV. Analysis was carried out at a scan rate from m/z 70 to 2200. Compounds were analyzed in the negative ion mode, and MS2 fragmentations were performed using Smart Frag mode [50,51].
The compounds were identified based on the literature data and by comparing with chemical standards.

4.8. Analysis of Polyphenol Content by HPLC-DAD

This analysis was performed using the HPLC-DAD method described in previous works [52,53]. Methanolic extract (prepared as described in Section 4.5) was used. A HPLC-DAD system (Merck-Hitachi, Merck KGaA, Darmstadt, Germany) and a Purospher RP-18e analytical column (4 × 250 nm, 5 mL; Merck) were used for the analysis. Elution was done with a mobile phase A (methanol:0.5% acetic acid, 1:4, v/v) and a mobile phase B (methanol). The gradient program was set as follows: 0–20 min, 0% B; 20–35 min, 0–20% B; 35–45 min, 20–30% B; 45–55 min, 30–40% B; 55–60 min, 40–50% B; 60–65 min, 50–75% B; and 65–70 min, 75–100% B. The hold time was 15 min. The other parameters were as follows: temperature, 25 °C; flow rate, 1 mL/min; injection volume, 10 μL; and detection wavelength, 254 nm. Quantitative analysis was carried for the following compounds detected using UHPLC-DAD-ESI-MS: p-coumaric acid, ferulic acid, gallic acid protocatechuic acid and rutoside (all compounds were purchased from Sigma-Aldrich Co. St. Louis, MO, USA).

4.9. Antioxidant Capacity

4.9.1. CUPRAC Assay of Total Antioxidant Capacity

The CUPRAC method described by Ozyurek et al. [54] and modified by Biesaga-Kościelniak et al. [55] was used to determine the total antioxidant activity in the extracts obtained from the tested biomass. For this, methanolic extracts of in vitro cultures and the parent plant herb (prepared as described in Section 4.5) were used. Briefly, 50 μL of the extracts was mixed with 50 μL aliquots of 10 mmol/L Cu2+, 7.5 mmol/L neocuproine, and 1 mol/L ammonia-acetate buffer (pH 7.0). Then, the samples were mixed and incubated for 15 min at 25 °C. Their absorbance was measured at 425 nm in 96-well plates (Synergy II, Biotek, Winooski, VT, USA). The antioxidant pool was determined and expressed as mmol TE/100 g DW. The measurements were performed in triplicate (including reagents blank).

4.9.2. FRAP Assay

The antioxidant potential of the extracts obtained from the tested biomass was also estimated using the FRAP method [56]. This analysis was done in 96-well plates. Briefly, 10 mmol/L solution of TPTZ (2,4,6-tris(2-pyridyl)-s-triazine) in 40 mmol/L HCl was mixed with 20 mmol/L of FeCl3⋅6H2O and 300 mmol/L of pH 3.6 acetate buffer (1/1/10, v/v/v). Then, 50 µL of plant extract was mixed with 150 µL of the prepared chromophore. After incubation for 5 min, the absorbance of the sample was read at 593 nm (Synergy II, Biotek, Winooski, VT, USA). The measurements were done in triplicate (including reagents blank).

4.9.3. DPPH Radical-Scavenging Activity Assay

The free radical-scavenging activity of the extracts was determined using the stable radical DPPH [57]. For this assay, plant extract (50 µL) was added to 150 µL of DPPH methanolic solution. The sample was mixed and incubated for 60 min, and then its absorbance was read at 517 nm (Synergy II, Biotek, Winooski, VT, USA). The measurements were performed in triplicate (including reagents blank).

4.10. Anti-Inflammatory Activity

The methanolic extracts of N. officinale herb and 10-days bioreactor RITA® microshoot cultures of the plant were assayed for anti-inflammatory activity. Briefly, the plant extracts and in vitro extracts were serially diluted with methanol (concentrations: 165.0, 16.5, and 1.7 µg/mL). The anti-inflammatory activity of the extracts was tested based on the in vitro inhibition of 15-LOX, COX-1, COX-2, and sPLA2 enzymes. All the samples were measured in triplicate (100% enzyme activity, positive control inhibitor, plant extract and compound vehicle control samples).
The percent of inhibition was calculated according to the Equation (1):
% Inh   =   ( IA   −   Inhibitor IA )   ×   100
where %Inh is the percent of inhibition and IA is 100% enzyme activity (without inhibitor), and Inhibitor represents the enzyme activity with inhibitor added.

4.10.1. Inhibitory Activity Against 15-LOX

The inhibitory activity of the extracts against 15-LOX was tested using an assay kit (760700; Cayman Chem. Co., Ann Arbor, MI, USA) according to the manufacturer’s instructions. The assay involves the monitoring of hydroperoxides produced during lipooxygenation using purified soy 15-LOX with arachidonic acid as a substrate and 100 µmol/L nordihydroguaiaretic acid (NDGA) as a positive control inhibitor. The absorbance was measured in a 96-well plate (Synergy II, Biotek, Winooski, VT, USA) at 490 nm.

4.10.2. Inhibitory Activity Against COX-1 and COX-2

The inhibitory activity of the extracts against COX-1 and COX-2 was tested using COX-1 (ovine) and COX-2 (human) inhibitor assay, with the peroxidase component of cyclooxygenase enzymes (701050; Cayman Chem. Co., Ann Arbor, MI, USA). The analysis was conducted according to the manufacturer’s instructions, with arachidonic acid (1.1 mmol/L) used as the substrate and 10 µmol/L ibuprofen as a positive control inhibitor. The increase in absorbance was monitored in a 96-well plate at 590 nm (Synergy II, Biotek, Winooski, VT, USA).

4.10.3. Inhibitory Activity against sPLA2

The sPLA2 inhibitory activity of the extracts was tested using an assay kit (10004883; Cayman Chem. Co.) according to the manufacturer’s instructions. The method utilized human recombinant type V sPLA. Thiols released due to the cleavage of diheptanoyl thio-PC were measured kinetically using DTNB (Ellman’s reagent) at 420 nm (Synergy II, Biotek, Winooski, VT, USA). Thioetheramide-PC (1-palmitylthio-2-palmitoylamido-1,2-dideoxy-sn-glycero-3-phosphorylcholine) (100 µmol/L) was used as a positive control inhibitor.

4.11. Antimicrobial Activity

The extracts of 10-days bioreactor microshoot cultures and the N. officinale herb were also screened for antibacterial and antifungal activities using the microdilution broth method. The antimicrobial activity analysis was conducted according to the guidelines of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) [58]. Mueller–Hinton broth and Mueller–Hinton broth with 5% lysed sheep blood were used for the growth of nonfastidious and fastidious bacteria, respectively, while RPMI (Roswell Park Memorial Institute Medium) with MOPS (3-(N-morpholino)propanesulfonic acid) was used for the growth of fungi as we described elsewhere [59,60]. The MIC of the tested derivatives was determined for a wide panel of reference microorganisms from the American Type Culture Collection (ATCC), including Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 9027, Helicobacter pylori ATCC 43504), Gram-positive bacteria (Staphylococcus aureus ATCC 25923, Staphylococcus aureus ATCC 43300, Staphylococcus epidermidis ATCC 12228), and fungi (Candida albicans ATCC 10231, Candida parapsilosis ATCC 22019, Candida glabrata ATCC 90030, Aspergillus niger ATCC 16404, Trichophyton mentagrophytes ATCC 9533, Penicillum chrysogenum ATCC 10106, Microsporum canis clinical strain). Each experiment was done in triplicate, and representative data were presented.

5. Conclusions

This study analyzed, for the first time, the presence of GSLs, phenolic acids, and flavonoids in N. officinale microshoot cultures cultivated in TIS RITA® bioreactors and evaluated the antioxidant, anti-inflammatory, and antimicrobial potential of the culture extracts. The results were compared with those obtained for the herb of the N. officinale parent plant.
In the bioreactor microshoot cultures, the Gi was very high and dependent on the duration of growth periods. The qualitative and quantitative analyses of GSLs and phenolic compounds confirmed the differences between the RITA® TIS microshoot cultures and parent plant material.
The content of total GSLs, polyphenols, and flavonoids were found to be comparable or higher in the extracts from RITA® bioreactor microshoot cultures than the parent plant herb.
Bioreactor microshoot cultures showed the lower production of the main GSLs (gluconasturtiin) and total GSLs but a higher amount of tryptophan-derived GSLs (glucobrassicin and 4-methoxyglucobrassicin), compared to parent plant extracts.
The antioxidant potential of the extracts from in vitro and in vivo plant materials was comparable. The highest accumulation of secondary metabolites and highest antioxidant activity were observed for extracts from 10-days bioreactor cultures. These extracts were also assessed for anti-inflammatory and antimicrobial activities, and it was found that the extracts from bioreactor microshoot cultures and parent plant material differed in the studied biological activities. We assume that the observed biological activities are mainly due to the GSL compounds, which were found as dominant in the studied extracts [17,18,19,20].
These results suggest the high potential of using RITA® TIS for growing N. officinale microshoot cultures on a large scale. These cultures can be used as an alternative source of health-promoting compounds to parent plant material.

Supplementary Materials

The following are available online, Figure S1: The chromatograms of the desulfoglucosinolates standards used, Figure S2: UV-Vis and MS2 spectra at 15V ionization of all desulfoglucosinolates detected. Numbers correspond to the Table 2.

Author Contributions

Conceptualization, A.S., M.K.-S.; methodology, M.K.-S., A.S., M.D., I.B., A.Đ., S.G., I.K.-G.; formal analysis, M.K.-S., A.S., M.D., I.B., A.Đ., S.G., I.K.-G., investigation, M.K.-S., A.S., M.D., I.B., A.Đ., S.G., I.K.-G., data curation, A.S., M.K.-S., M.D.; writing—original draft preparation, A.S., M.K.-S., H.E.; visualization, M.K.-S., A.S.; funding acquisition, M.K.-S., I.B.; critical revision of the manuscript: A.S., H.E., M.D., I.B., A.Đ.; contributed in writing and formatting the final version: M.K.-S., A.S., H.E., M.D., I.B., A.Đ., S.G., I.K.-G. All authors participated in conducting experiments, writing and approving the final manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

The research was realized as a part of the research project supported by the Polish Ministry of Science and Higher Education (Grant PL: N/42/DBS/000122), and the Croatian Science Foundation (Grant IP-2016-06-1316).

Acknowledgments

I.B. is also thankful for the scientific-research equipment financed by EU grant KK.01.1.1.02.0018.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Król, A.; Kokotkiewicz, A.; Szopa, A.; Ekiert, H.; Luczkiewicz, M. Bioreactor-grown shoot cultures for the secondary metabolite production. In Plant Cell and Tissue Differentiation and Secondary Metabolites; Ramawat, K.G., Ekiert, H.M., Goyal, S., Eds.; Springer: Cham, Switzerland, 2020; ISBN 9783030112530. [Google Scholar] [CrossRef]
  2. Yancheva, S.; Georgieva, L.; Badjakov, I.; Dincheva, I.; Georgieva, M.; Georgiev, V.; Kondakova, V. Application of bioreactor technology in plant propagation and secondary metabolite production. J. Cent. Eur. Agric. 2019, 20, 321–340. [Google Scholar] [CrossRef]
  3. Steingroewer, J.; Bley, T.; Georgiev, V.; Ivanov, I.; Lenk, F.; Marchev, A.; Pavlov, A. Bioprocessing of differentiated plant in vitro systems. Eng. Life Sci. 2013, 13, 26–38. [Google Scholar] [CrossRef]
  4. Kokotkiewicz, A.; Bucinski, A.; Luczkiewicz, M. Xanthone, benzophenone and bioflavonoid accumulation in Cyclopia genistoides (L.) Vent. (honeybush) shoot cultures grown on membrane rafts and in a temporary immersion system. Plant Cell. Tissue Organ. Cult. 2015, 120, 373–378. [Google Scholar] [CrossRef] [Green Version]
  5. Jang, H.R.; Lee, H.J.; Shohael, A.M.; Park, B.J.; Paek, K.Y.; Park, S.Y. Production of biomass and bioactive compounds from shoot cultures of Rosa rugosa using a bioreactor culture system. Hortic. Environ. Biotechnol. 2016, 57, 79–87. [Google Scholar] [CrossRef]
  6. Valdez-Tapia, R.; Capataz-Tafur, J.; López-Laredo, A.R.; Trejo-Espino, J.L.; Trejo-Tapia, G. Effect of immersion cycles on growth, phenolics content, and antioxidant properties of Castilleja tenuiflora shoots. In Vitr. Cell. Dev. Biol. Plant 2014, 50, 471–477. [Google Scholar] [CrossRef]
  7. Schumann, A.; Berkov, S.; Claus, D.; Gerth, A.; Bastida, J.; Codina, C. Production of galanthamine by Leucojum aestivum shoots grown in different bioreactor systems. Appl. Biochem. Biotechnol. 2012, 167, 1907–1920. [Google Scholar] [CrossRef]
  8. Sankar-Thomas, Y.D.; Lieberei, R. Camptothecin accumulation in various organ cultures of Camptotheca acuminata Decne grown in different culture systems. Plant Cell. Tissue Organ Cult. 2011, 106, 445–454. [Google Scholar] [CrossRef]
  9. International Union for Conservation of Nature (IUCN). The IUCN Red List of Threatened Species. Available online: https://www.iucnredlist.org/ (accessed on 22 July 2020).
  10. German Comission E Monographie BGA/BfArM, Kommission E, 22a ed.; 1990. Available online: https://buecher.heilpflanzen-welt.de/BGA-Kommission-E-Monographien/ (accessed on 23 May 2020).
  11. European Food Safety Authority (EFSA). Available online: http://www.efsa.europa.eu/ (accessed on 25 May 2020).
  12. Boligon, A.A.; Janovik, V.; Boligon, A.A.; Pivetta, C.R.; Pereira, R.P.; Da Rocha, J.B.T.; Athayde, M.L. HPLC analysis of polyphenolic compounds and antioxidant activity in Nasturtium officinale. Int. J. Food Prop. 2013, 16, 61–69. [Google Scholar] [CrossRef]
  13. Martínez-Sánchez, A.; Gil-Izquierdo, A.; Gil, M.I.; Ferreres, F. A comparative study of flavonoid compounds, vitamin C, and antioxidant properties of baby leaf Brassicaceae species. J. Agric. Food Chem. 2008, 56, 2330–2340. [Google Scholar] [CrossRef]
  14. Afsharypuor, S.; Salehi, M. Volatile constituents of leaves and stems of Nasturtium officinale R. Br. J. Essent. Oil Res. 2008, 20, 517–518. [Google Scholar] [CrossRef]
  15. Jeon, J.; Bong, S.J.; Park, J.S.; Park, Y.K.; Arasu, M.V.; Al-Dhabi, N.A.; Park, S.U. De novo transcriptome analysis and glucosinolate profiling in watercress (Nasturtium officinale R. Br.). BMC Genom. 2017, 18, 1–14. [Google Scholar] [CrossRef] [PubMed]
  16. Giallourou, N.; Oruna-Concha, M.J.; Harbourne, N. Effects of domestic processing methods on the phytochemical content of watercress (Nasturtium officinale). Food Chem. 2016, 212, 411–419. [Google Scholar] [CrossRef] [PubMed]
  17. Bahramikia, S.; Yazdanparast, R. Antioxidant efficacy of Nasturtium officinale extracts using various in vitro assay systems. JAMS J. Acupunct. Meridian Stud. 2010, 3, 283–290. [Google Scholar] [CrossRef]
  18. Sadeghi, H.; Mostafazadeh, M.; Sadeghi, H.; Naderian, M.; Barmak, M.J.; Talebianpoor, M.S.; Mehraban, F. In vivo anti-inflammatory properties of aerial parts of Nasturtium officinale. Pharm. Biol. 2014, 52, 169–174. [Google Scholar] [CrossRef] [PubMed]
  19. Li, Q.; Zhan, M.; Chen, W.; Zhao, B.; Yang, K.; Yang, J.; Yi, J.; Huang, Q.; Mohan, M.; Hou, Z.; et al. Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1. Oncotarget 2016, 7, 10271–10282. [Google Scholar] [CrossRef] [Green Version]
  20. Holst, B.; Williamson, G. A critical review of the bioavailability of glucosinolates and related compounds. Nat. Prod. Rep. 2004, 21, 425–447. [Google Scholar] [CrossRef]
  21. Wainwright, H.; Marsh, J. The micropropagation of watercress (Rorippa nasturtium-aquaticum L.). J. Hortic. Sci. 1986, 61, 251–256. [Google Scholar] [CrossRef]
  22. Wielanek, M.; Królicka, A.; Bergier, K.; Gajewska, E.; Skłodowska, M. Transformation of Nasturtium officinale, Barbarea verna and Arabis caucasica for hairy roots and glucosinolate-myrosinase system production. Biotechnol. Lett. 2009, 31, 917–921. [Google Scholar] [CrossRef]
  23. Park, N.I.; Kim, J.K.; Park, W.T.; Cho, J.W.; Lim, Y.P.; Park, S.U. An efficient protocol for genetic transformation of watercress (Nasturtium officinale) using Agrobacterium rhizogenes. Mol. Biol. Rep. 2011, 38, 4947–4953. [Google Scholar] [CrossRef]
  24. Klimek-Szczykutowicz, M.; Szopa, A.; Dziurka, M.; Komsta, Ł.; Tomczyk, M.; Ekiert, H. The Influence of Nasturtium officinale R. Br. agar and agitated microshoot culture media on glucosinolate and phenolic acid production, and antioxidant activity. Biomolecules 2020, 10, 1216. [Google Scholar] [CrossRef]
  25. Klimek-Szczykutowicz, M.; Szopa, A.; Blicharska, E.; Dziurka, M.; Komsta, Ł.; Ekiert, H. Bioaccumulation of selected macro- and microelements and their impact on antioxidant properties and accumulation of glucosinolates and phenolic acids in in vitro cultures of Nasturtium officinale (watercress) microshoots. Food Chem. 2019, 300, 125184. [Google Scholar] [CrossRef] [PubMed]
  26. Jesionek, A.; Kokotkiewicz, A.; Wlodarska, P.; Zabiegala, B.; Bucinski, A.; Luczkiewicz, M. Bioreactor shoot cultures of Rhododendron tomentosum (Ledum palustre) for a large-scale production of bioactive volatile compounds. Plant Cell. Tissue Organ Cult. 2017, 131, 51–64. [Google Scholar] [CrossRef] [Green Version]
  27. Szopa, A.; Kokotkiewicz, A.; Bednarz, M.; Jafernik, K.; Luczkiewicz, M.; Ekiert, H. Bioreactor type affects the accumulation of phenolic acids and flavonoids in microshoot cultures of Schisandra chinensis (Turcz.) Baill. Plant Cell. Tissue Organ Cult. 2019, 139, 199–206. [Google Scholar] [CrossRef] [Green Version]
  28. Verpoorte, R.; Van Der Hejden, R.; Ten Hoopen, H.J.G.; Memelink, J. Metabolic engineering of plant secondary metabolite pathways for the production of fine chemicals. Biotechnol. Lett. 1999, 21, 467–479. [Google Scholar] [CrossRef]
  29. Karuppusamy, S. A review on trends in production of secondary metabolites from higher plants by in vitro tissue, organ and cell cultures. J. Med. Plants Res. 2009, 3, 1222–1239. [Google Scholar]
  30. Isah, T.; Umar, S.; Mujib, A.; Sharma, M.P.; Rajasekharan, P.E.; Zafar, N.; Frukh, A. Secondary metabolism of pharmaceuticals in the plant in vitro cultures: Strategies, approaches, and limitations to achieving higher yield. Plant Cell. Tissue Organ Cult. 2018, 132, 239–265. [Google Scholar] [CrossRef]
  31. Gallaher, C.M.; Gallaher, D.D.; Peterson, S. Development and validation of a spectrophotometric method for quantification of total glucosinolates in Cruciferous vegetables. J. Agric. Food Chem. 2012, 60, 1358–1362. [Google Scholar] [CrossRef]
  32. Rubin, E.; Aziz, Z.A.; Surugau, N. Glucosinolates content of in vitro grown Nasturtium officinale (watercress). ASM Sci. J. 2018, 11, 132–139. [Google Scholar]
  33. Zeb, A. Phenolic profile and antioxidant potential of wild watercress (Nasturtium officinale L.). Springerplus 2015, 4, 1–7. [Google Scholar] [CrossRef] [Green Version]
  34. Aires, A.; Carvalho, R.; Rosa, E.A.S.; Saavedra, M.J. Phytochemical characterization and antioxidant properties of baby-leaf watercress produced under organic production system. CYTA J. Food 2013, 11, 343–351. [Google Scholar] [CrossRef]
  35. Herz, C.; Márton, M.R.; Tran, H.T.T.; Gründemann, C.; Schell, J.; Lamy, E. Benzyl isothiocyanate but not benzyl nitrile from Brassicales plants dually blocks the COX and LOX pathway in primary human immune cells. J. Funct. Foods 2016, 23, 135–143. [Google Scholar] [CrossRef]
  36. Burčul, F.; Generalić Mekinić, I.; Radan, M.; Rollin, P.; Blažević, I. Isothiocyanates: Cholinesterase inhibiting, antioxidant, and anti-inflammatory activity. J. Enzyme Inhib. Med. Chem. 2018, 33, 577–582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Almuhayawi, M.S.; AbdElgawad, H.; Al Jaouni, S.K.; Selim, S.; Hassan, A.H.A.; Khamis, G. Elevated CO2 improves glucosinolate metabolism and stimulates anticancer and anti-inflammatory properties of broccoli sprouts. Food Chem. 2020, 328, 127102. [Google Scholar] [CrossRef] [PubMed]
  38. Camponogara, C.; Silva, C.R.; Brusco, I.; Piana, M.; Faccin, H.; de Carvalho, L.M.; Schuch, A.; Trevisan, G.; Oliveira, S.M. Nasturtium officinale R. Br. effectively reduces the skin inflammation induced by croton oil via glucocorticoid receptor-dependent and NF-κB pathways without causing toxicological effects in mice. J. Ethnopharmacol. 2019, 229, 190–204. [Google Scholar] [CrossRef]
  39. French, G.L. Bactericidal agents in the treatment of MRSA infections—The potential role of daptomycin. J. Antimicrob. Chemother. 2006, 58, 1107–1117. [Google Scholar] [CrossRef] [Green Version]
  40. Zafar, R.; Zahoor, M.; Shah, A.B.; Majid, F. Determination of antioxidants and antibacterial activities, total phenolic, polyphenol and pigment contents in Nasturtium officinale. Pharmacologyonline 2017, 1, 11–18. [Google Scholar]
  41. Quezada-Lázaro, R.; Fernández-Zuñiga, E.A.; García, A.; Garza-González, E.; Alvarez, L.; Camacho-Corona, M.R. Antimycobacterial compounds from Nasturtium officinale. Afr. J. Tradit. Complement. Altern. Med. 2016, 13, 31–34. [Google Scholar] [CrossRef] [Green Version]
  42. Murashige, T.; Skoog, F. A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol. Plant. 1962, 15, 473–497. [Google Scholar] [CrossRef]
  43. Blažević, I.; Đulović, A.; Čikeš Čulić, V.; Burčul, F.; Ljubenkov, I.; Ruščić, M.; Generalić Mekinić, I. Bunias erucago L.: Glucosinolate profile and in vitro biological potential. Molecules 2019, 24, 741. [Google Scholar]
  44. Grosser, K.; van Dam, N.M. A straightforward method for glucosinolate extraction and analysis with high-pressure liquid chromatography (HPLC). J. Vis. Exp. 2017, 2017, 1–9. [Google Scholar] [CrossRef] [Green Version]
  45. Brown, P.D.; Tokuhisa, J.G.; Reichelt, M.; Gershenzon, J. Variation of glucosinolate accumulation among different organs and developmental stages of Arabidopsis thaliana. Phytochemistry 2003, 62, 471–481. [Google Scholar] [CrossRef]
  46. Wathelet, J.P.; Iori, R.; Leoni, O.; Quinsac, O.; Palmieri, S. Guidelines for glucosinolate analysis in green tissues used for biofumigation. Agroindustria 2004, 3, 257–266. [Google Scholar]
  47. Singleton, V.L.; Orthofer, R.; Lamuela-Raventos, R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzym. 1999, 299, 152–178. [Google Scholar]
  48. Bach, A.; Kapczyńska, A.; Dziurka, K.; Dziurka, M. Phenolic compounds and carbohydrates in relation to bulb formation in Lachenalia “Ronina” and “Rupert” in vitro cultures under different lighting environments. Sci. Hortic. (Amsterdam) 2015, 188, 23–29. [Google Scholar] [CrossRef]
  49. Ramos, R.T.M.; Bezerra, I.C.F.; Ferreira, M.R.A.; Soares, L.A.L. Spectrophotometric quantification of flavonoids in herbal material, crude extract, and fractions from leaves of Eugenia uniflora Linn. Pharmacognosy Res. 2017, 9, 253–260. [Google Scholar]
  50. Czerwinska, M.E.; Swierczewska, A.; Granica, S. Bioactive constituents of Lamium album L. as inhibitors of cytokine secretion in human neutrophils. Molecules 2018, 23, 2770. [Google Scholar] [CrossRef] [Green Version]
  51. Granica, S.; Czerwińska, M.E.; Piwowarski, J.P.; Ziaja, M.; Kiss, A.K. Chemical composition, antioxidative and anti-inflammatory activity of extracts prepared from aerial parts of Oenothera biennis L. and Oenothera paradoxa Hudziok obtained after seeds cultivation. J. Agric. Food Chem. 2013, 61, 801–810. [Google Scholar] [CrossRef]
  52. Ellnain-Wojtaszek, M.; Zgórka, G. High-performance liquid chromatography and thin-layer chromatography of phenolic acids from Gingko biloba L. leaves collected within vegetative period. J. Liq. Chromatogr. Relat. Technol. 1999, 22, 1457–1471. [Google Scholar] [CrossRef]
  53. Sułkowska-Ziaja, K.; Maślanka, A.; Szewczyk, A.; Muszyńska, B. Physiologically active compounds in four species of genus Phellinus. Nat. Prod. Commun. 2017, 12, 363–366. [Google Scholar]
  54. Özyürek, M.; Güçlü, K.; Bektaşoğlu, B.; Apak, R. Spectrophotometric determination of ascorbic acid by the modified CUPRAC method with extractive separation of flavonoids–La(III) complexes. Anal. Chim. Acta 2007, 588, 88–95. [Google Scholar] [CrossRef]
  55. Biesaga-Kościelniak, J.; Dziurka, M.; Ostrowska, A.; Mirek, M.; Kościelniak, J.; Janeczko, A. Brassinosteroid improves content of antioxidants in seeds of selected leguminous plants. Aust. J. Crop Sci. 2014, 8, 378–388. [Google Scholar]
  56. Benzie, I.F.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measuer of “antioxidant power”: The FRAP assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Blios, M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 26, 1199–1200. [Google Scholar] [CrossRef]
  58. EUCAST. Available online: www.eucast.org (accessed on 1 June 2020).
  59. Sermukhamedova, O.; Wojtanowski, K.K.; Widelski, J.; Korona-Glowniak, I.; Elansary, H.O.; Sakipova, Z.; Malm, A.; Głowniak, K.; Skalicka-Wozniak, K. Metabolic profile of and antimicrobial activity in the aerial part of Leonurus turkestanicus V.I. Krecz. et Kuprian. from Kazakhstan. J. AOAC Int. 2017, 100, 1700–1705. [Google Scholar] [CrossRef] [PubMed]
  60. Korona-Glowniak, I.; Glowniak-Lipa, A.; Ludwiczuk, A.; Baj, T.; Malm, A. The in vitro activity of essential oils against Helicobacter pylori growth and urease activity. Molecules 2020, 25, 586. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Molecules 25 05257 g001 550
Figure 1. Microshoot cultures of N. officinale cultivated in bioreactor RITA® TIS on MS medium containing 1 mg/L BA and 1 mg/L NAA after: 10 days of growth period (a); 20 days of growth period (b); and the herb of N. officinale (c).
Figure 1. Microshoot cultures of N. officinale cultivated in bioreactor RITA® TIS on MS medium containing 1 mg/L BA and 1 mg/L NAA after: 10 days of growth period (a); 20 days of growth period (b); and the herb of N. officinale (c).
Molecules 25 05257 g001
Molecules 25 05257 g002 550
Figure 2. Chromatograms of desulfoglucosinolates (dGSLs): RW1—extract of 10-days bioreactors microshoot cultures, RW2—extract of 20-days bioreactors microshoot cultures, RW3—extract of N. officinale herb. For compound numbers, refer to Table 2.
Figure 2. Chromatograms of desulfoglucosinolates (dGSLs): RW1—extract of 10-days bioreactors microshoot cultures, RW2—extract of 20-days bioreactors microshoot cultures, RW3—extract of N. officinale herb. For compound numbers, refer to Table 2.
Molecules 25 05257 g002
Molecules 25 05257 g003 550
Figure 3. UHPLC-DAD-ESI-MS chromatogram of N. officinale extract from bioreactors cultures and the herb of the parent plant separation of the phenolic compounds (at 254 and 325 nm). For compound numbers, refer to Table 3. RW1—extract of N. officinale herb, RW4—extract of N. officinale bioreactors microshoot cultures.
Figure 3. UHPLC-DAD-ESI-MS chromatogram of N. officinale extract from bioreactors cultures and the herb of the parent plant separation of the phenolic compounds (at 254 and 325 nm). For compound numbers, refer to Table 3. RW1—extract of N. officinale herb, RW4—extract of N. officinale bioreactors microshoot cultures.
Molecules 25 05257 g003
Table
Table 1. Total GSLs, polyphenols and flavonoids contents in N. officinale extracts from bioreactor microshoot cultures and the herb of the parent plant.
Table 1. Total GSLs, polyphenols and flavonoids contents in N. officinale extracts from bioreactor microshoot cultures and the herb of the parent plant.
In Vitro CulturesPlant Material
Growth Cycles (Days)
1020
Total glucosionolates (GSLs)
(mg/100 g DW ± SD)		261.97 ± 21.14 113.70 ± 13.84799.47 ± 4.89
Total polyphenols
(mmol TE/100 g DW ± SD)		3.74 ± 0.253.10 ± 0.192.70 ± 0.31
Total flavonoids
(mmol RE/100 g DW ± SD)		1.64 ± 0.080.95 ± 0.031.89 ± 0.20
Data expressed as the mean value ± SD (n = 3), TE—trolox equivalent, RE—rutoside equivalent.
Table
Table 2. GSLs profile and quantitative content of detected compounds in N. officinale extracts from bioreactor microshoot cultures and the herb of the parent plant confirmed by UHPLC-DAD-MS/MS.
Table 2. GSLs profile and quantitative content of detected compounds in N. officinale extracts from bioreactor microshoot cultures and the herb of the parent plant confirmed by UHPLC-DAD-MS/MS.
No.Glucosinolate (GSL)
(Trivial Name)		tR
(min)		[M + Na]+Content (mg/100 g DW ± SD)
In Vitro CulturesPlant Material
Growth Cycles (Days)
10 Days20 Days
Met derived16-(Methylsulfinyl)hexyl GSL
(Glucohesperin)		5.20408ndtrtr
27-(Methylsulfinyl)heptyl GSL6.20422trtr92.27 ± 0.48
38-(Methylsulfinyl)octyl GSL
(Glucohirsutin)		7.20436trtr42.79 ± 0.49
47-(Methylsulfanyl)heptyl GSL10.60406ndndtr
58-(Methylsulfanyl)octyl GSL12.37420ndndtr
Phe derived62-Phenylethyl GSL
(Gluconasturtiin)		7.70366182.93 ± 4.6656.32 ± 7.62640.94 ± 2.96
Trp derived7Indol-3-ylmethyl GSL
(Glucobrassicin)		7.0039120.18 ± 4.047.62 ± 0.01tr
84-Methoxyindol-3-ylmethyl GSL
(4-Methoxyglucobrassicin)		7.8042158.86 ± 12.4449.76 ± 6.2223.47 ± 0.96
[M + Na]+, sodium adduct of desulfoglucosinolate; DW, dry weight; tr < 0.1 μmol/g DW; nd, not detected. Data are expressed as the mean value ± SD (n = 3). Met derived—methionine-derived glucosinolates; Phe derived—phenylalanine-derived glucosinolates; Trp derived—tryptophan-derived glucosinolates.
Table
Table 3. Phenolic profile and contents of detected compounds in N. officinale extracts from bioreactor microshoots cultures and from the herb of the parent plant confirmed by UHPLC-DAD-ESI-MS and HPLC-DAD.
Table 3. Phenolic profile and contents of detected compounds in N. officinale extracts from bioreactor microshoots cultures and from the herb of the parent plant confirmed by UHPLC-DAD-ESI-MS and HPLC-DAD.
No.CompoundtR (min)UV-Vis[M − H]- m/zMS2 IonsContent (mg/100 g DW ± SD)
In Vitro CulturesPlant Material
Growth Cycles (Days)
10 Days20 Days
9Gallic acid s3.4269169125ndnd26.55 ± 4.72
10Protocatechuic acid s4.1258, 287152-ndnd196.11 ± 18.23
11Undefined compound9.7260426-ndndnd
12Undefined compound15.0253283-ndndnd
13Undefined compound16.2250337-ndndnd
14Protocatechuic acid derivative20.4258, 287387153ndndnd
15Caffeic acid derivative22.1280, 323325163ndndnd
16Undefined compound22.9264417207ndndnd
17Phenolic acid derivative24.8295, 309431385, 223ndndnd
18Caffeic acid derivative25.3297, 325355265, 217, 193ndndnd
19Gluconasturtiin s28.1220422342, 259, 229, 180ndndnd
20Glucohirsutin t28.4220492428, 275ndndnd
21Phenolic acid derivative28.8300, 318308175ndndnd
22Caffeic acid derivative33.3298, 323363319, 244, 161ndndnd
23Caffeic acid derivative35.3300, 328695651, 489ndndnd
24p-Coumaric acid s36.73131631331.26 ± 0.021.05 ± 0.013.10 ± 0.21
25Ferulic acid s39.9260, 327193-9.28 ± 0.871.66 ± 0.2312.69 ± 1.13
26Rutoside s41.3overlaped6093013.06 ± 0.2823.24 ± 1.987.20 ± 0.67
27Isoquercitrin s42.1260, 351463301ndnd57.05 ± 5.11
28Kaempferol O-rhamnohexoside45.6260, 341593447, 285ndnd0.18 ± 0.02
29Sinapic acid derivative51.3264, 336753529, 289, 223ndndnd
30 Undefined compound66.8230329-ndndnd
31Undefined compound71.9225307289, 235, 185ndndnd
32Undefined compound73.7231311293, 181, 155ndndnd
s—authentic standard was used for comparison, t—tentative assignment, nd-not detected. Data expressed as the mean value ± SD (n = 3).
Table
Table 4. Antioxidant potential estimated by CUPRAC, FRAP and DPPH methods (expressed in mmol TE/100 g DW ± SD) in N. officinale extracts from bioreactor microshoot cultures and from the herb of the parent plant.
Table 4. Antioxidant potential estimated by CUPRAC, FRAP and DPPH methods (expressed in mmol TE/100 g DW ± SD) in N. officinale extracts from bioreactor microshoot cultures and from the herb of the parent plant.
MethodIn Vitro CulturesPlant Material
Growth Cycles (Days)
10 Days20 Days
CUPRAC3.19 ± 0.202.46 ± 0.124.45 ± 0.02
FRAP0.75 ± 0.050.67 ± 0.200.76 ± 0.08
DPPH21.63 ± 2.77 23.79 ± 3.6226.32 ± 8.23
CUPRAC—CUPric reducing antioxidant activity, FRAP—Ferric Reducing Ability of Plasma, DPPH—1,1-diphenyl-2-picrylhydrazyl assays; TE—trolox equivalent. Data expressed as the mean value ± SD (n = 3).
Table
Table 5. In vitro inhibition activity (%Inh ± SD) of studied extracts from N. officinale microshoot cultures grown in RITA® bioreactors over 10 days growth periods, and N. officinale herb extracts against 15-LOX, COX-1, COX-2 and sPLA2 enzymes.
Table 5. In vitro inhibition activity (%Inh ± SD) of studied extracts from N. officinale microshoot cultures grown in RITA® bioreactors over 10 days growth periods, and N. officinale herb extracts against 15-LOX, COX-1, COX-2 and sPLA2 enzymes.
MaterialConcentrations (µg/mL)%Inh ± SD
15-LOXCOX-1COX-2sPLA2
In vitro cultures165.0no inhibition33.3 ± 3.734.5 ± 3.83.8 ± 0.2
16.515.9 ± 1.140.5 ± 4.573.5 ± 8.11.3 ± 0.1
1.7no inhibition29.2 ± 3.275.4 ± 8.30.7 ± 0.1
Plant material165.0no inhibition41.1 ± 4.539.8 ± 4.42.1 ± 0.1
16.519.5 ± 1.436.3 ± 4.041.1 ± 4.5no inhibition
1.7no inhibition42.6 ± 4.733.0 ± 3.65.3 ± 0.2
ControlNDGA30.2 (100 µM)23.0 ± 2.0------
Ibuprofen2.1 (10 µM)--23.0 ± 2.521.0 ± 2.0--
Thioetheramide-PC73.6 (100 µM)------91.0 ± 4.0
15-LOX—15-lipoxygenase, COX-1 and -2, cyclooxygenase-1 and -2, sPLA2—phospholipase A2 enzymes; %Inh—percent of enzyme activity inhibition; SD—standard deviation (n = 3), NDGA—nordihydroguaiaretic acid; Thioetheramide-PC—1-palmitylthio-2-palmitoylamido-1,2-dideoxy-sn-glycero-3-phosphorylcholine.
Table
Table 6. Antimicrobial activity of studied extracts from N. officinale microshoot cultures grown in RITA® bioreactors over 10 days growth periods, and N. officinale herb extracts, against selected bacterial and fungi strains.
Table 6. Antimicrobial activity of studied extracts from N. officinale microshoot cultures grown in RITA® bioreactors over 10 days growth periods, and N. officinale herb extracts, against selected bacterial and fungi strains.
MicroorganismIn Vitro CulturesPlant Material
MIC (mg/mL)MBC or MFC (mg/mL)MBC/MIC or MFC/MIC RatioMIC (mg/mL)MBC or MFC (mg/mL)MBC/MIC or MFC/MIC Ratio
Gram(+) bacteriaStaphylococcus aureus ATCC 2592351025102
Staphylococcus aureus ATCC 4330052045204
Staphylococcus epidermidis ATCC12228510210101
Gram(-) bacteriaEscherichia coli
ATCC 25922		1010110101
Pseudomonas aeruginosa ATCC 90271010110101
Helicobacter pylori
ATCC 43504		1.251.2511.251.251
FungiCandida albicans
ATCC 102231		102025102
Candida parapsilosis
ATCC 22019		2020110202
Candida glabrata
ATCC 90030		1010110101
Aspergillusniger
ATCC 16404		10>20nd10>20nd
Penicillum chrysogenum ATCC 1010610>20nd10>20nd
Trichophyton menthagrophytes
ATCC 9533		1.252.522.52.51
Microsporum canis
clinical strain		520410202
nd—not detected; MIC—minimal inhibitory concentration; MBC—minimum bactericidal concentration; MFC—minimum fungicidal concentration.
Sample Availability: Samples are not available from the authors.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Klimek-Szczykutowicz, M.; Dziurka, M.; Blažević, I.; Đulović, A.; Granica, S.; Korona-Glowniak, I.; Ekiert, H.; Szopa, A. Phytochemical and Biological Activity Studies on Nasturtium officinale (Watercress) Microshoot Cultures Grown in RITA® Temporary Immersion Systems. Molecules 2020, 25, 5257. https://doi.org/10.3390/molecules25225257

AMA Style

Klimek-Szczykutowicz M, Dziurka M, Blažević I, Đulović A, Granica S, Korona-Glowniak I, Ekiert H, Szopa A. Phytochemical and Biological Activity Studies on Nasturtium officinale (Watercress) Microshoot Cultures Grown in RITA® Temporary Immersion Systems. Molecules. 2020; 25(22):5257. https://doi.org/10.3390/molecules25225257

Chicago/Turabian Style

Klimek-Szczykutowicz, Marta, Michał Dziurka, Ivica Blažević, Azra Đulović, Sebastian Granica, Izabela Korona-Glowniak, Halina Ekiert, and Agnieszka Szopa. 2020. "Phytochemical and Biological Activity Studies on Nasturtium officinale (Watercress) Microshoot Cultures Grown in RITA® Temporary Immersion Systems" Molecules 25, no. 22: 5257. https://doi.org/10.3390/molecules25225257

Article Metrics

Back to TopTop